| Southern Eye Associates Of South Carolina, Pa | |
|
113 Doctors Dr, Greenville, SC 29605-5608 | |
| (864) 269-3333 | |
| (864) 295-1288 |
| Full Name | Southern Eye Associates Of South Carolina, Pa |
|---|---|
| Type | Facility |
| Speciality | Ophthalmology |
| Location | 113 Doctors Dr, Greenville, South Carolina |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215933510 | NPI | - | NPPES |
| 1396841599 | Other | SC | NPI |
| 335998 | Medicaid | SC | |
| 52668 | Medicaid | SC | |
| 1053369777 | Other | SC | NPI |
| DA9608 | Medicaid | SC | |
| 153549 | Medicaid | SC | |
| 1548218340 | Other | SC | NPI |
| 6180 | Other | SC | MEDICARE GROUP NUMBER GREER OFFICE |
| 1760431035 | Other | SC | NPI |
| D17998 | Medicaid | SC | |
| TL5190 | Medicaid | SC | |
| 130735 | Medicaid | SC | |
| 1437107836 | Other | SC | NPI |
| 1639127046 | Other | SC | NPI |
| PA6449 | Medicaid | SC | |
| T48026 | Medicaid | SC | |
| 1205122975 | Other | MO | NPI |
| 1571 | Other | SC | MEDICARE GROUP GREENVILLE OFFICE NUMBER |
| 1821439878 | Other | SC | NPI |
| 1295886125 | Other | SC | NPI |
| GP2766 | Medicaid | SC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | (* (Not Available)) | Secondary |
| 207W00000X | Ophthalmology | (* (Not Available)) | Primary |
| Provider Name | Bradley B Williams |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1437107836 PECOS PAC ID: 8527025790 Enrollment ID: I20050215000204 |
News Archive
XTL Biopharmaceuticals Ltd., a biopharmaceutical development company, announced on November 21st that it has acquired 4,620,356 shares, of Proteologics Ltd., from Teva Pharmaceutical Industries Ltd. in consideration for an amount of approximately NIS 6.5 million, which represents an amount of NIS 1.405 per Share (approximately 22% premium).
The aim of this study was to develop a screening tool to identify infants prior to 12 months at risk for autism spectrum disorder (ASD) and developmental learning delay (DLD) and provide immediate determination of risk for autism spectrum disorder.
Sheila Taylor leaned in to see the baby's heartbeat rhythm. She watched as the baby's heartbeat line fell without a corresponding spike showing the mother's uterus contracting down on it.
A new Canadian study suggests that the youngest children in a family are not less likely than older siblings to develop multiple sclerosis (MS).
The 2007 UNAIDS/WHO AIDS epidemic update released last week has revised the global estimate of HIV/AIDS primarily due to a major reduction of the estimate for India to 2.5 million people living with HIV/AIDS, which is less than half of the previous official estimate of 5.7 million people.
› Verified 7 days ago
| Provider Name | Kurt F Heitman |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1548218340 PECOS PAC ID: 1355399023 Enrollment ID: I20050215000235 |
News Archive
XTL Biopharmaceuticals Ltd., a biopharmaceutical development company, announced on November 21st that it has acquired 4,620,356 shares, of Proteologics Ltd., from Teva Pharmaceutical Industries Ltd. in consideration for an amount of approximately NIS 6.5 million, which represents an amount of NIS 1.405 per Share (approximately 22% premium).
The aim of this study was to develop a screening tool to identify infants prior to 12 months at risk for autism spectrum disorder (ASD) and developmental learning delay (DLD) and provide immediate determination of risk for autism spectrum disorder.
Sheila Taylor leaned in to see the baby's heartbeat rhythm. She watched as the baby's heartbeat line fell without a corresponding spike showing the mother's uterus contracting down on it.
A new Canadian study suggests that the youngest children in a family are not less likely than older siblings to develop multiple sclerosis (MS).
The 2007 UNAIDS/WHO AIDS epidemic update released last week has revised the global estimate of HIV/AIDS primarily due to a major reduction of the estimate for India to 2.5 million people living with HIV/AIDS, which is less than half of the previous official estimate of 5.7 million people.
› Verified 7 days ago
| Provider Name | Douglas W Stokes |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1639127046 PECOS PAC ID: 3971560145 Enrollment ID: I20050215000248 |
News Archive
XTL Biopharmaceuticals Ltd., a biopharmaceutical development company, announced on November 21st that it has acquired 4,620,356 shares, of Proteologics Ltd., from Teva Pharmaceutical Industries Ltd. in consideration for an amount of approximately NIS 6.5 million, which represents an amount of NIS 1.405 per Share (approximately 22% premium).
The aim of this study was to develop a screening tool to identify infants prior to 12 months at risk for autism spectrum disorder (ASD) and developmental learning delay (DLD) and provide immediate determination of risk for autism spectrum disorder.
Sheila Taylor leaned in to see the baby's heartbeat rhythm. She watched as the baby's heartbeat line fell without a corresponding spike showing the mother's uterus contracting down on it.
A new Canadian study suggests that the youngest children in a family are not less likely than older siblings to develop multiple sclerosis (MS).
The 2007 UNAIDS/WHO AIDS epidemic update released last week has revised the global estimate of HIV/AIDS primarily due to a major reduction of the estimate for India to 2.5 million people living with HIV/AIDS, which is less than half of the previous official estimate of 5.7 million people.
› Verified 7 days ago
| Provider Name | William R Steigerwald |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1396841599 PECOS PAC ID: 0547268781 Enrollment ID: I20110715000441 |
News Archive
XTL Biopharmaceuticals Ltd., a biopharmaceutical development company, announced on November 21st that it has acquired 4,620,356 shares, of Proteologics Ltd., from Teva Pharmaceutical Industries Ltd. in consideration for an amount of approximately NIS 6.5 million, which represents an amount of NIS 1.405 per Share (approximately 22% premium).
The aim of this study was to develop a screening tool to identify infants prior to 12 months at risk for autism spectrum disorder (ASD) and developmental learning delay (DLD) and provide immediate determination of risk for autism spectrum disorder.
Sheila Taylor leaned in to see the baby's heartbeat rhythm. She watched as the baby's heartbeat line fell without a corresponding spike showing the mother's uterus contracting down on it.
A new Canadian study suggests that the youngest children in a family are not less likely than older siblings to develop multiple sclerosis (MS).
The 2007 UNAIDS/WHO AIDS epidemic update released last week has revised the global estimate of HIV/AIDS primarily due to a major reduction of the estimate for India to 2.5 million people living with HIV/AIDS, which is less than half of the previous official estimate of 5.7 million people.
› Verified 7 days ago
| Provider Name | Peter Goodwin |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1649488594 PECOS PAC ID: 1951471275 Enrollment ID: I20111013000461 |
News Archive
XTL Biopharmaceuticals Ltd., a biopharmaceutical development company, announced on November 21st that it has acquired 4,620,356 shares, of Proteologics Ltd., from Teva Pharmaceutical Industries Ltd. in consideration for an amount of approximately NIS 6.5 million, which represents an amount of NIS 1.405 per Share (approximately 22% premium).
The aim of this study was to develop a screening tool to identify infants prior to 12 months at risk for autism spectrum disorder (ASD) and developmental learning delay (DLD) and provide immediate determination of risk for autism spectrum disorder.
Sheila Taylor leaned in to see the baby's heartbeat rhythm. She watched as the baby's heartbeat line fell without a corresponding spike showing the mother's uterus contracting down on it.
A new Canadian study suggests that the youngest children in a family are not less likely than older siblings to develop multiple sclerosis (MS).
The 2007 UNAIDS/WHO AIDS epidemic update released last week has revised the global estimate of HIV/AIDS primarily due to a major reduction of the estimate for India to 2.5 million people living with HIV/AIDS, which is less than half of the previous official estimate of 5.7 million people.
› Verified 7 days ago
| Provider Name | Craig Allen Odell |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1821439878 PECOS PAC ID: 5597989921 Enrollment ID: I20140605000089 |
News Archive
XTL Biopharmaceuticals Ltd., a biopharmaceutical development company, announced on November 21st that it has acquired 4,620,356 shares, of Proteologics Ltd., from Teva Pharmaceutical Industries Ltd. in consideration for an amount of approximately NIS 6.5 million, which represents an amount of NIS 1.405 per Share (approximately 22% premium).
The aim of this study was to develop a screening tool to identify infants prior to 12 months at risk for autism spectrum disorder (ASD) and developmental learning delay (DLD) and provide immediate determination of risk for autism spectrum disorder.
Sheila Taylor leaned in to see the baby's heartbeat rhythm. She watched as the baby's heartbeat line fell without a corresponding spike showing the mother's uterus contracting down on it.
A new Canadian study suggests that the youngest children in a family are not less likely than older siblings to develop multiple sclerosis (MS).
The 2007 UNAIDS/WHO AIDS epidemic update released last week has revised the global estimate of HIV/AIDS primarily due to a major reduction of the estimate for India to 2.5 million people living with HIV/AIDS, which is less than half of the previous official estimate of 5.7 million people.
› Verified 7 days ago
| Provider Name | Wade Alex Reardon |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1205122975 PECOS PAC ID: 4183939531 Enrollment ID: I20150814013291 |
News Archive
XTL Biopharmaceuticals Ltd., a biopharmaceutical development company, announced on November 21st that it has acquired 4,620,356 shares, of Proteologics Ltd., from Teva Pharmaceutical Industries Ltd. in consideration for an amount of approximately NIS 6.5 million, which represents an amount of NIS 1.405 per Share (approximately 22% premium).
The aim of this study was to develop a screening tool to identify infants prior to 12 months at risk for autism spectrum disorder (ASD) and developmental learning delay (DLD) and provide immediate determination of risk for autism spectrum disorder.
Sheila Taylor leaned in to see the baby's heartbeat rhythm. She watched as the baby's heartbeat line fell without a corresponding spike showing the mother's uterus contracting down on it.
A new Canadian study suggests that the youngest children in a family are not less likely than older siblings to develop multiple sclerosis (MS).
The 2007 UNAIDS/WHO AIDS epidemic update released last week has revised the global estimate of HIV/AIDS primarily due to a major reduction of the estimate for India to 2.5 million people living with HIV/AIDS, which is less than half of the previous official estimate of 5.7 million people.
› Verified 7 days ago
| Provider Name | Jeffrey Van Swearingen |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1972656692 PECOS PAC ID: 6103018643 Enrollment ID: I20161220000542 |
News Archive
XTL Biopharmaceuticals Ltd., a biopharmaceutical development company, announced on November 21st that it has acquired 4,620,356 shares, of Proteologics Ltd., from Teva Pharmaceutical Industries Ltd. in consideration for an amount of approximately NIS 6.5 million, which represents an amount of NIS 1.405 per Share (approximately 22% premium).
The aim of this study was to develop a screening tool to identify infants prior to 12 months at risk for autism spectrum disorder (ASD) and developmental learning delay (DLD) and provide immediate determination of risk for autism spectrum disorder.
Sheila Taylor leaned in to see the baby's heartbeat rhythm. She watched as the baby's heartbeat line fell without a corresponding spike showing the mother's uterus contracting down on it.
A new Canadian study suggests that the youngest children in a family are not less likely than older siblings to develop multiple sclerosis (MS).
The 2007 UNAIDS/WHO AIDS epidemic update released last week has revised the global estimate of HIV/AIDS primarily due to a major reduction of the estimate for India to 2.5 million people living with HIV/AIDS, which is less than half of the previous official estimate of 5.7 million people.
› Verified 7 days ago
| Provider Name | Stanley Tyler Pace |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1366717605 PECOS PAC ID: 4284927054 Enrollment ID: I20180712002538 |
News Archive
XTL Biopharmaceuticals Ltd., a biopharmaceutical development company, announced on November 21st that it has acquired 4,620,356 shares, of Proteologics Ltd., from Teva Pharmaceutical Industries Ltd. in consideration for an amount of approximately NIS 6.5 million, which represents an amount of NIS 1.405 per Share (approximately 22% premium).
The aim of this study was to develop a screening tool to identify infants prior to 12 months at risk for autism spectrum disorder (ASD) and developmental learning delay (DLD) and provide immediate determination of risk for autism spectrum disorder.
Sheila Taylor leaned in to see the baby's heartbeat rhythm. She watched as the baby's heartbeat line fell without a corresponding spike showing the mother's uterus contracting down on it.
A new Canadian study suggests that the youngest children in a family are not less likely than older siblings to develop multiple sclerosis (MS).
The 2007 UNAIDS/WHO AIDS epidemic update released last week has revised the global estimate of HIV/AIDS primarily due to a major reduction of the estimate for India to 2.5 million people living with HIV/AIDS, which is less than half of the previous official estimate of 5.7 million people.
› Verified 7 days ago
| Provider Name | Andrew Ernest Hack |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1770927212 PECOS PAC ID: 9335429554 Enrollment ID: I20180716002786 |
News Archive
XTL Biopharmaceuticals Ltd., a biopharmaceutical development company, announced on November 21st that it has acquired 4,620,356 shares, of Proteologics Ltd., from Teva Pharmaceutical Industries Ltd. in consideration for an amount of approximately NIS 6.5 million, which represents an amount of NIS 1.405 per Share (approximately 22% premium).
The aim of this study was to develop a screening tool to identify infants prior to 12 months at risk for autism spectrum disorder (ASD) and developmental learning delay (DLD) and provide immediate determination of risk for autism spectrum disorder.
Sheila Taylor leaned in to see the baby's heartbeat rhythm. She watched as the baby's heartbeat line fell without a corresponding spike showing the mother's uterus contracting down on it.
A new Canadian study suggests that the youngest children in a family are not less likely than older siblings to develop multiple sclerosis (MS).
The 2007 UNAIDS/WHO AIDS epidemic update released last week has revised the global estimate of HIV/AIDS primarily due to a major reduction of the estimate for India to 2.5 million people living with HIV/AIDS, which is less than half of the previous official estimate of 5.7 million people.
› Verified 7 days ago
| Provider Name | Peter Benjamin Daniel |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1831500206 PECOS PAC ID: 9537447768 Enrollment ID: I20190703000440 |
News Archive
XTL Biopharmaceuticals Ltd., a biopharmaceutical development company, announced on November 21st that it has acquired 4,620,356 shares, of Proteologics Ltd., from Teva Pharmaceutical Industries Ltd. in consideration for an amount of approximately NIS 6.5 million, which represents an amount of NIS 1.405 per Share (approximately 22% premium).
The aim of this study was to develop a screening tool to identify infants prior to 12 months at risk for autism spectrum disorder (ASD) and developmental learning delay (DLD) and provide immediate determination of risk for autism spectrum disorder.
Sheila Taylor leaned in to see the baby's heartbeat rhythm. She watched as the baby's heartbeat line fell without a corresponding spike showing the mother's uterus contracting down on it.
A new Canadian study suggests that the youngest children in a family are not less likely than older siblings to develop multiple sclerosis (MS).
The 2007 UNAIDS/WHO AIDS epidemic update released last week has revised the global estimate of HIV/AIDS primarily due to a major reduction of the estimate for India to 2.5 million people living with HIV/AIDS, which is less than half of the previous official estimate of 5.7 million people.
› Verified 7 days ago
| Provider Name | Scott Andrew Mogavero |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1033780754 PECOS PAC ID: 4284012923 Enrollment ID: I20220608000905 |
News Archive
XTL Biopharmaceuticals Ltd., a biopharmaceutical development company, announced on November 21st that it has acquired 4,620,356 shares, of Proteologics Ltd., from Teva Pharmaceutical Industries Ltd. in consideration for an amount of approximately NIS 6.5 million, which represents an amount of NIS 1.405 per Share (approximately 22% premium).
The aim of this study was to develop a screening tool to identify infants prior to 12 months at risk for autism spectrum disorder (ASD) and developmental learning delay (DLD) and provide immediate determination of risk for autism spectrum disorder.
Sheila Taylor leaned in to see the baby's heartbeat rhythm. She watched as the baby's heartbeat line fell without a corresponding spike showing the mother's uterus contracting down on it.
A new Canadian study suggests that the youngest children in a family are not less likely than older siblings to develop multiple sclerosis (MS).
The 2007 UNAIDS/WHO AIDS epidemic update released last week has revised the global estimate of HIV/AIDS primarily due to a major reduction of the estimate for India to 2.5 million people living with HIV/AIDS, which is less than half of the previous official estimate of 5.7 million people.
› Verified 7 days ago
| Provider Name | Charles Andrew Pickens |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1760120885 PECOS PAC ID: 5698154599 Enrollment ID: I20220623001977 |
News Archive
XTL Biopharmaceuticals Ltd., a biopharmaceutical development company, announced on November 21st that it has acquired 4,620,356 shares, of Proteologics Ltd., from Teva Pharmaceutical Industries Ltd. in consideration for an amount of approximately NIS 6.5 million, which represents an amount of NIS 1.405 per Share (approximately 22% premium).
The aim of this study was to develop a screening tool to identify infants prior to 12 months at risk for autism spectrum disorder (ASD) and developmental learning delay (DLD) and provide immediate determination of risk for autism spectrum disorder.
Sheila Taylor leaned in to see the baby's heartbeat rhythm. She watched as the baby's heartbeat line fell without a corresponding spike showing the mother's uterus contracting down on it.
A new Canadian study suggests that the youngest children in a family are not less likely than older siblings to develop multiple sclerosis (MS).
The 2007 UNAIDS/WHO AIDS epidemic update released last week has revised the global estimate of HIV/AIDS primarily due to a major reduction of the estimate for India to 2.5 million people living with HIV/AIDS, which is less than half of the previous official estimate of 5.7 million people.
› Verified 7 days ago
| Provider Name | Justin W Lee |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1285670513 PECOS PAC ID: 0749414639 Enrollment ID: I20220908002874 |
News Archive
XTL Biopharmaceuticals Ltd., a biopharmaceutical development company, announced on November 21st that it has acquired 4,620,356 shares, of Proteologics Ltd., from Teva Pharmaceutical Industries Ltd. in consideration for an amount of approximately NIS 6.5 million, which represents an amount of NIS 1.405 per Share (approximately 22% premium).
The aim of this study was to develop a screening tool to identify infants prior to 12 months at risk for autism spectrum disorder (ASD) and developmental learning delay (DLD) and provide immediate determination of risk for autism spectrum disorder.
Sheila Taylor leaned in to see the baby's heartbeat rhythm. She watched as the baby's heartbeat line fell without a corresponding spike showing the mother's uterus contracting down on it.
A new Canadian study suggests that the youngest children in a family are not less likely than older siblings to develop multiple sclerosis (MS).
The 2007 UNAIDS/WHO AIDS epidemic update released last week has revised the global estimate of HIV/AIDS primarily due to a major reduction of the estimate for India to 2.5 million people living with HIV/AIDS, which is less than half of the previous official estimate of 5.7 million people.
› Verified 7 days ago
| Provider Name | Melissa Anne Ixcamey |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1245761055 PECOS PAC ID: 5698044246 Enrollment ID: I20230601003180 |
News Archive
XTL Biopharmaceuticals Ltd., a biopharmaceutical development company, announced on November 21st that it has acquired 4,620,356 shares, of Proteologics Ltd., from Teva Pharmaceutical Industries Ltd. in consideration for an amount of approximately NIS 6.5 million, which represents an amount of NIS 1.405 per Share (approximately 22% premium).
The aim of this study was to develop a screening tool to identify infants prior to 12 months at risk for autism spectrum disorder (ASD) and developmental learning delay (DLD) and provide immediate determination of risk for autism spectrum disorder.
Sheila Taylor leaned in to see the baby's heartbeat rhythm. She watched as the baby's heartbeat line fell without a corresponding spike showing the mother's uterus contracting down on it.
A new Canadian study suggests that the youngest children in a family are not less likely than older siblings to develop multiple sclerosis (MS).
The 2007 UNAIDS/WHO AIDS epidemic update released last week has revised the global estimate of HIV/AIDS primarily due to a major reduction of the estimate for India to 2.5 million people living with HIV/AIDS, which is less than half of the previous official estimate of 5.7 million people.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Southern Eye Associates Of South Carolina, Pa 113 Doctors Dr, Greenville, SC 29605-5608 Ph: (864) 269-3333 | Southern Eye Associates Of South Carolina, Pa 113 Doctors Dr, Greenville, SC 29605-5608 Ph: (864) 269-3333 |
News Archive
XTL Biopharmaceuticals Ltd., a biopharmaceutical development company, announced on November 21st that it has acquired 4,620,356 shares, of Proteologics Ltd., from Teva Pharmaceutical Industries Ltd. in consideration for an amount of approximately NIS 6.5 million, which represents an amount of NIS 1.405 per Share (approximately 22% premium).
The aim of this study was to develop a screening tool to identify infants prior to 12 months at risk for autism spectrum disorder (ASD) and developmental learning delay (DLD) and provide immediate determination of risk for autism spectrum disorder.
Sheila Taylor leaned in to see the baby's heartbeat rhythm. She watched as the baby's heartbeat line fell without a corresponding spike showing the mother's uterus contracting down on it.
A new Canadian study suggests that the youngest children in a family are not less likely than older siblings to develop multiple sclerosis (MS).
The 2007 UNAIDS/WHO AIDS epidemic update released last week has revised the global estimate of HIV/AIDS primarily due to a major reduction of the estimate for India to 2.5 million people living with HIV/AIDS, which is less than half of the previous official estimate of 5.7 million people.
› Verified 7 days ago